BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8910 related articles for article (PubMed ID: 17921107)

  • 1. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases.
    Conill C; Berenguer J; Vargas M; López-Soriano A; Valduvieco I; Marruecos J; Vilella R
    Clin Transl Oncol; 2007 Sep; 9(9):590-5. PubMed ID: 17921107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy After Stereotactic Radiosurgery for Brain Metastases.
    Trifiletti DM; Lee CC; Schlesinger D; Larner JM; Xu Z; Sheehan JP
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):870-8. PubMed ID: 26530756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases.
    Ebi J; Sato H; Nakajima M; Shishido F
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1212-7. PubMed ID: 23102839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.
    Monaco EA; Faraji AH; Berkowitz O; Parry PV; Hadelsberg U; Kano H; Niranjan A; Kondziolka D; Lunsford LD
    Cancer; 2013 Jan; 119(1):226-32. PubMed ID: 22707281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for cerebral metastases.
    Sneed PK; Larson DA; Wara WM
    Neurosurg Clin N Am; 1996 Jul; 7(3):505-15. PubMed ID: 8823778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Rades D; Heisterkamp C; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
    Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
    Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs.
    Nieder C; Leicht A; Motaref B; Nestle U; Niewald M; Schnabel K
    Am J Clin Oncol; 1999 Dec; 22(6):573-9. PubMed ID: 10597741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases.
    Jiang C; Kleber TJ; Switchenko JM; Khan MK
    Radiat Oncol; 2021 Feb; 16(1):31. PubMed ID: 33557890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study.
    Koo T; Kim K; Park HJ; Han SW; Kim TY; Jeong SY; Park KJ; Chie EK
    Sci Rep; 2020 Mar; 10(1):4340. PubMed ID: 32152433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
    Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
    Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
    Kondziolka D; Patel A; Lunsford LD; Kassam A; Flickinger JC
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):427-34. PubMed ID: 10487566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases.
    Dobi Á; Fodor E; Maráz A; Együd Z; Cserháti A; Tiszlavicz L; Reisz Z; Barzó P; Varga Z; Hideghéty K
    Pathol Oncol Res; 2020 Jan; 26(1):149-157. PubMed ID: 29344836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 446.